Observation of effect of dexmedetomidine when given intravenously to the pediatric patients undergoing levobupivacaine spinal anaesthesia.

Completed

Brief Summary: 1) Spinal anaesthesia in pediatric patient is reliable.

2) Levobupivacaine 0.5% isobaric in recommended dose can produce effective sensory and motor block.

3)When data of this study was compared with other study it can be inferred that dexmedetomidine 0.5% microgram/kg given before spinal anaesthesia can prolong the duration of sensory effect.

4)Sedation for procedure as well as during surgery is required in more number of smaller children than older children.

5)Dexmedetomidine 0.5%microgram/kg can be safely used in children between 2-12 year of age.

6)Spinal anaesthesia in pediatric patients is not associated with much perioperative complications.

Recruitment & Eligibility

Inclusion Criteria

class-1 and class-2 patients 2) lower abdominal surgery 3) 2 year to 12 year age.

Exclusion Criteria

Primary Outcome Measures

Name	Time	Method
Intravenous dexmedetomidine prolong the effect of bupivacaine spinal anaesthesia	end of clinical trial

Secondary Outcome Measures

Name	Time	Method
provide haemodynamic stability.	provide good intraoperative sedation and pain free period during operation and postoperative period

Locations (1): Government medical college
🇮🇳
Surat, GUJARAT, India
Government medical college
🇮🇳Surat, GUJARAT, India
drvaibhavsonavia
Principal investigator
9099934244
dr.vaibhavsonavia@yahoo.com